Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis.
Kekki
M
M
Kurki
T
T
Paavonen
J
J
Rutanen
E M
EM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015415:Biomarkers; D002584:Cervix Uteri / Q000382:microbiology*; D002981:Clindamycin / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000302:isolation & purification*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000188:drug therapy; D016585:Vaginosis, Bacterial / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D015415:Biomarkers; D018970:Insulin-Like Growth Factor Binding Protein 1; D002981:Clindamycin